Recruiting at 1 site No phase Smoking Cessation

Clinical trial for Smoking Cessation

Official title Leveraging Community Pharmacists to Optimize Smoking Cessation Services for Rural Smokers in Appalachia

ClinicalTrials.gov ID: NCT05660525

What this study is testing

What is 4 weeks of Nicotine lozenge?

This is an investigational nicotine replacement therapy being studied to help people quit smoking. It is designed to temporarily replace nicotine from tobacco to reduce the urge to smoke and withdrawal symptoms.

Also referred to as Sunmark Nicotine Polacrilex Lozenge, Habitrol Nicotine Lozenge, Nicotinell Nicotine Lozenge, Nicorette Lozenge.

Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.

What it's testing
The study will see if QuitAid, alone or with other quit aids, helps people stop smoking, and whether it is easy to use, affordable, and sustainable.
Who it's for
Adults who live in rural Appalachia and smoke cigarettes.
What's involved
Participants will receive at least 4 weeks of nicotine patches. Some will be randomly assigned to extra treatments such as a texting quit program, a quitline with four phone calls, 8 weeks of nicotine replacement, or a different combination of patches and lozenges. All will also get the QuitAid coaching from their pharmacist.
Time commitment
The program lasts about 8 weeks, with regular visits to the pharmacist and possible phone or text check‑ins.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older. Healthy volunteers may be eligible.

You may be able to join if

  • must be 18 years of age and older
  • must be able to read, speak, and understand English
  • must report smoking at least 5 cigarettes per day for the past 6 months (regardless of non-cigarette tobacco product use)
  • must be willing to set a quit date within the next 30 days
  • must own a cell phone

You likely can't join if

  • are pregnant women (self-reported), breastfeeding, planning to become pregnant during the next 6 months
  • have a medical contraindication to NRT (e.g., past 30 days, heart attack or stroke
See the full eligibility criteria
Who can join
  • must be 18 years of age and older
  • must be able to read, speak, and understand English
  • must report smoking at least 5 cigarettes per day for the past 6 months (regardless of non-cigarette tobacco product use)
  • must be willing to set a quit date within the next 30 days
  • must own a cell phone
  • must be willing and able to use NRT in the form of patch or lozenge
  • Not be pregnant or planning to be pregnant in the next 6 months.
What rules you out
  • are pregnant women (self-reported), breastfeeding, planning to become pregnant during the next 6 months
  • have a medical contraindication to NRT (e.g., past 30 days, heart attack or stroke; past 6 months, serious or worsening angina, very rapid or irregular heartbeat requiring medication)

The study team makes the final eligibility decision.

Where it is enrolling

  • Charlottesville, Virginia, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Charlottesville, Virginia, United States. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.